Getinge and Neobiomics received Swecare's export awards

Two companies received awards during Swecare's annual conference.

Norway rejects national life science strategy – sees no need

The Norwegian Arbeiderpartiet rejects a proposal that Norway should develop its own life science strategy.

Product demo with features, software and best-practices

Get interesting insights about ZEISS O-INSPECT duo in our demo recording.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

Pharma Outsourcing – Find the Right Partner (2026)

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Improve Productivity and Accessibility with Award-winning Human-Centered Design

Enhance your workflow with integrated intelligence.

Nytt läkemedel mot cystisk fibros rekommenderas för EU-godkännande

Ett nytt läkemedel för cystisk fibros har fått ett positivt utlåtande av CHMP, den europeiska läkemedelsmyndigheten EMA:s vetenskapliga kommitté för humanläkemedel.

Achieve Efficient, Fast Targeting of Your Sample

Step into the future of imaging technology with VersaXRM 730.

Galderma

CTC Clinical Trial Consultants AB

TECHNIA AB

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Partial court victory for entrepreneur who lost his company

Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...

A new scientific event in Gothenburg

Life Science Sweden is holding an event in Gothenburg for the first time.

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Ny framgång för Genmabs behandling mot livmoderhalscancer

Danska Genmabs antikroppskonjugat för behandling mot avancerad eller återkommande livmoderhalscancer får europeiskt godkännande.

KI-forskare har upptäckt biomarkörer för postcovid

Forskare vid Karolinska institutet har i en ny studie identifierat en uppsättning proteiner i blod hos personer med långvariga besvär av postcovid.

Assignment: Facilitate the retention of foreign researchers

A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.